“Under the current structure dictated by PAMA, the severity of fee reductions would undermine the operational infrastructure of clinical laboratories throughout the United States,” says Donald S Karcher, MD, FCAP, CAP president, in a release. “The RESULTS Act will mitigate these cuts, avert needless loss in access to care, and allow laboratories to continue providing timely, high-quality clinical services for patients.”
For the full article click here: Bipartisan legislation aims to overhaul the PAMA rate-setting process that has cut $4 billion in cuts to clinical laboratory services in three years, according to ACLA.